Table 1 Clinical characteristics
Characteristic | n(%) |
|---|---|
Total | 253 |
Gender | |
 Male | 216(85.4%) |
 Female | 37(14.6%) |
Age (years) | |
  ≤ 47 | 133(52.6%) |
  > 47 | 122(47.4%) |
T stage # | |
 T1 | 12(4.7%) |
 T2 | 22(8.7%) |
 T3 | 133(52.6%) |
 T4 | 86(34.0%) |
N stage # | |
 N0 | 4(1.6%) |
 N1 | 28(11.1%) |
 N2 | 94(37.2%) |
 N3 | 127(50.2%) |
Metastatic sites | |
 Bone | 116(45.8%) |
 Lung | 28(11.1%) |
 Liver | 14(5.5%) |
 Distant nodes | 22(8.7%) |
 Multiple sites | 73(28.9%) |
LRRT use | |
 No | 89(35.2%) |
 Yes | 164(64.8%) |